We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JBH:ASXJB Hi-Fi Limited Analysis

Data as of 2026-03-11 - not real-time

A$78.71

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

JB Hi‑Fi is trading at AU$78.71, which sits below its 20‑day SMA of 81.54 and 50‑day SMA of 85.23, indicating short‑term weakness. The RSI is around 41, suggesting the stock is not yet oversold, while the MACD histogram remains negative, confirming bearish momentum. Price is above the identified support at AU$72.26 but well under the resistance of AU$90.13, and the 30‑day volatility of over 40% points to sizable price swings. Despite the technical softness, the DCF fair‑value estimate of AU$88.03 offers roughly 17% upside, and the company delivers a solid 4% dividend yield with a 62% payout ratio backed by strong free cash flow. Fundamentals are robust: revenue grew 7.3% YoY, ROE stands at 29%, and operating margins are healthy, while the balance sheet shows manageable debt (debt‑to‑equity ~43%). Recent half‑year results sparked a market rally to AU$89.10, highlighting investor optimism.
Overall, JB Hi‑Fi appears undervalued relative to its intrinsic value, benefits from a sustainable dividend, and possesses a resilient business model, though short‑term technical indicators remain bearish and volatility is elevated.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and elevated volatility
  • Attractive dividend yield and cash flow

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~17% to fair value
  • Consistent earnings growth and strong ROE
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable retail and services franchise across Australia and NZ
  • High return on equity and solid free cash flow generation
  • Undervalued valuation metrics relative to intrinsic worth

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin4.40%
P/E Ratio17.9
ROE29.24%
ROA10.69%
Debt/Equity43.39
P/B Ratio5.1
Op. Cash FlowA$665.1M
Free Cash FlowA$519.5M

Technical Analysis

TrendBearish
RSI41.0
SupportA$72.26
ResistanceA$90.13
MA 20A$81.54
MA 50A$85.23
MA 200A$102.65
MACDBearish
VolumeDecreasing
Fear & Greed Index76.3

Valuation

Fair ValueA$88.03
Target PriceA$92.64
Upside/Downside17.70%
GradeUndervalued
TypeBlend
Dividend Yield4.00%

Risk Assessment

Beta0.45
Volatility41.74%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.